Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Consolidated Quarterly Results - Sequent Scientific

Sequent Scientific

BSE: 512529|NSE: SEQUENT|ISIN: INE807F01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 22, 12:50
64.35
-1.3 (-1.98%)
VOLUME 20,034
LIVE
NSE
Nov 22, 12:51
64.50
-0.9 (-1.38%)
VOLUME 132,389
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Consolidated Quarterly Results of Sequent Scientific

------------------- in Rs. Cr. -------------------
Sep '19 Jun '19 Mar '19 Dec '18 Sep '18
Net Sales/Income from operations 284.22 278.02 281.90 270.53 251.72
Other Operating Income -- -- -- -- --
Total Income From Operations 284.22 278.02 281.90 270.53 251.72
EXPENDITURE
Consumption of Raw Materials 122.54 120.03 152.22 98.73 97.85
Purchase of Traded Goods 18.31 22.27 15.38 33.14 34.58
Increase/Decrease in Stocks 9.91 0.81 -23.42 9.39 -1.36
Power & Fuel -- -- -- -- --
Employees Cost 40.80 39.71 39.47 36.88 34.46
Depreciation 12.46 12.01 10.92 11.16 10.20
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 55.51 56.75 59.25 56.71 58.47
P/L Before Other Inc., Int., Excpt. Items & Tax 24.70 26.43 28.08 24.53 17.53
Other Income 5.97 1.31 2.43 1.99 2.44
P/L Before Int., Excpt. Items & Tax 30.67 27.74 30.50 26.52 19.98
Interest 7.84 8.95 8.90 8.35 7.77
P/L Before Exceptional Items & Tax 22.83 18.80 21.60 18.17 12.20
Exceptional Items -- -- -- -- --
P/L Before Tax 22.83 18.80 21.60 18.17 12.20
Tax -1.64 3.50 0.28 2.60 -3.30
P/L After Tax from Ordinary Activities 24.47 15.30 21.33 15.57 15.50
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 24.47 15.30 21.33 15.57 15.50
Minority Interest -3.18 -3.84 -4.20 -2.55 -0.27
Share Of P/L Of Associates -- -- -- -- --
Net P/L After M.I & Associates 21.29 11.46 17.12 13.03 15.23
Equity Share Capital 49.37 49.37 49.37 48.75 48.75
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.88 0.47 0.71 0.54 0.63
Diluted EPS 0.87 0.47 0.70 0.53 0.63
EPS After Extra Ordinary
Basic EPS 0.88 0.47 0.71 0.54 0.63
Diluted EPS 0.87 0.47 0.70 0.53 0.63
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Sequent Scienti

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for sequentscientific
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.